Literature DB >> 29599475

Precision oncology in non-small-cell lung cancer: opportunities and challenges.

Chul Kim1, Giuseppe Giaccone2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29599475     DOI： 10.1038/s41571-018-0008-0

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Evaluation of Exosomal miRNA in Blood as a Potential Diagnostic Biomarker for Human Non-Small Cell Lung Cancer.

Authors:  Zhenan Xu; Zhenxing Wang; Hongbin Sun; Hua Xin
Journal:  Med Sci Monit       Date:  2020-05-23

2.  DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR.

Authors:  Ji Geng; Rong Zhang; Xiao Yuan; Haidong Xu; Zhou Zhu; Xinxin Wang; Yan Wang; Guoqiang Xu; Wenjie Guo; Junchao Wu; Zheng-Hong Qin
Journal:  Cell Death Dis       Date:  2020-09-17       Impact factor: 8.469

3.  LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis.

Authors:  Kai Guo; Di Qi; Bo Huang
Journal:  Cancer Cell Int       Date:  2021-02-01       Impact factor: 5.722

4.  Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis.

Authors:  Xin Lv; Yingjie Lian; Zhanye Liu; Jianguang Xiao; Donghua Zhang; Xiaohua Yin
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

5.  Personalised Medicine: implication and perspectives in the field of occupational health.

Authors:  Valentina Bollati; Luca Ferrari; Veruscka Leso; Ivo Iavicoli
Journal:  Med Lav       Date:  2020-11-25       Impact factor: 1.275

6.  Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.

Authors:  Qing Ma; Kai Geng; Ping Xiao; Lili Zeng
Journal:  Biomed Res Int       Date:  2021-09-02       Impact factor: 3.411

7.  Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors.

Authors:  Lei Zhang; John Coffin; Kim Formenti; Quincy Chu; Iyare Izevbaye
Journal:  BMJ Open Respir Res       Date:  2022-01

Review 8.  The emerging potentials of lncRNA DRAIC in human cancers.

Authors:  Qinfan Yao; Xiuyuan Zhang; Dajin Chen
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

9.  Lin28A promotes the proliferation and stemness of lung cancer cells via the activation of mitogen-activated protein kinase pathway dependent on microRNA let-7c.

Authors:  Rui Zhang; Pengpeng Liu; Xiao Zhang; Yingnan Ye; Jinpu Yu
Journal:  Ann Transl Med       Date:  2021-06

10.  Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma.

Authors:  Chul Kim; Liqiang Xi; Constance M Cultraro; Fang Wei; Gregory Jones; Jordan Cheng; Ahmad Shafiei; Trinh Hoc-Tran Pham; Nitin Roper; Elizabeth Akoth; Azam Ghafoor; Vikram Misra; Nina Monkash; Charles Strom; Michael Tu; Wei Liao; David Chia; Clive Morris; Seth M Steinberg; Hadi Bagheri; David T W Wong; Mark Raffeld; Udayan Guha
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.575
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.